Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
Junhee Park, Min Kyu Kang
Radiat Oncol J. 2018;36(1):35-44.   Published online 2018 Mar 30     DOI: https://doi.org/10.3857/roj.2017.00311
Citations to this article as recorded by Crossref logo
Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation
Xue Ming, Jingfang Mao, Ningyi Ma, Jian Chen, Weiwei Wang, Yinxiangzi Sheng, Kailiang Wu
Physics in Medicine & Biology.2024; 69(1): 015025.     CrossRef
Sequential Versus Concurrent Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for N3 Limited-Stage Small-Cell Lung Cancer
Zhenbo Wang, Jinliang Wan, Changmin Liu, Lei Li, Xinjun Dong, Haitao Geng
Cancer Control.2020; 27(1): 107327482095661.     CrossRef
Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score
Tae Gyu Kim, Hongryull Pyo, Yong Chan Ahn, Jae Myoung Noh, Dongryul Oh
Journal of Radiation Research.2019; 60(5): 630.     CrossRef
Cisplatin/etoposide
Reactions Weekly.2018; 1701(1): 90.     CrossRef